LLC1
LLC1, an amiloride derivative, is a cytotoxic agent active against various breast cancer cell lines, including multidrug-resistant subtypes, with IC50 values ranging from 12 to 26 mM. It serves as a research tool for investigating novel oncology therapeutics in in vitro studies targeting treatment-resistant cancers.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog